Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giant's chips and technology for drug discovery.
Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giant's chips and technology for drug discovery.
Elevatus Welath Management acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 24,650 shares of the company’s stock, valued at approximately $243,000. Other institutional investors also recently bought and sold shares of the […]
You don't need to buy her picks, but it's worth understanding them.
You're doing something right if your company is worth $2.6 trillion like Nvidia. And it's worth looking at the companies Nvidia invests in.
SoundHound AI, an AI voice and conversation platform, has seen its shares rise on pace with the chipmaker this year